TY - JOUR
T1 - The needs for research ethics consultation service in Japan
T2 - A preliminary questionnaire survey
AU - Aizawa, Kuniko
AU - Nakada, Haruka
AU - Doi, Kaori
AU - Okita, Taketoshi
AU - Matsui, Kenji
N1 - Publisher Copyright:
© 2015 the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT).
PY - 2015
Y1 - 2015
N2 - Background: The research ethics consultation service(RECS)is an advisory service in which bioethicists evaluate research and development projects and assist in making sure that ethical principles are upheld within the projects. It has been implemented in several clinical research institutions and programs in Japan. However, the specific demand for this service has not yet been investigated. Objective: To identify the needs for RECS and its related factors among parties involved in clinical research. Design: An anonymous self-administered questionnaire survey delivered on site or by post. Participants: The questionnaire was administered to 144 ethics committee members and clinical research coordinators(CRC)from 78 institutions who participated in four research ethics seminars that we held in Kyoto, Tokyo and Osaka from December 2012 to January 2014. Survey period: December 2013 to February 2014. Measurements: Questionnaire with 11 multiple-choice questions. Results: 119 of 144 participants responded(return rate 82.6%). Of the respondents, 64.7% were research ethics committee members and officials, and 26.9% were CRCs. 54.6% were affiliated with universities and colleges. Irrespective of their roles and institutions, more than 90% answered that they themselves would like to use the RECS. While 37.0% preferred an institution-based service, 22.7% favored either a district-based service or service specialized for specific type or area of research. Limitations: The results obtained in this study may not be generalizable to the needs of all clinical research communities. Conclusions: We propose that public RECSs should be developed at 15 or more core research institutes in Japan to provide consultations in ethics to both ethics committees and CRCs across the country.
AB - Background: The research ethics consultation service(RECS)is an advisory service in which bioethicists evaluate research and development projects and assist in making sure that ethical principles are upheld within the projects. It has been implemented in several clinical research institutions and programs in Japan. However, the specific demand for this service has not yet been investigated. Objective: To identify the needs for RECS and its related factors among parties involved in clinical research. Design: An anonymous self-administered questionnaire survey delivered on site or by post. Participants: The questionnaire was administered to 144 ethics committee members and clinical research coordinators(CRC)from 78 institutions who participated in four research ethics seminars that we held in Kyoto, Tokyo and Osaka from December 2012 to January 2014. Survey period: December 2013 to February 2014. Measurements: Questionnaire with 11 multiple-choice questions. Results: 119 of 144 participants responded(return rate 82.6%). Of the respondents, 64.7% were research ethics committee members and officials, and 26.9% were CRCs. 54.6% were affiliated with universities and colleges. Irrespective of their roles and institutions, more than 90% answered that they themselves would like to use the RECS. While 37.0% preferred an institution-based service, 22.7% favored either a district-based service or service specialized for specific type or area of research. Limitations: The results obtained in this study may not be generalizable to the needs of all clinical research communities. Conclusions: We propose that public RECSs should be developed at 15 or more core research institutes in Japan to provide consultations in ethics to both ethics committees and CRCs across the country.
KW - Japan
KW - Needs
KW - Questionnaire
KW - Research ethics consultation
UR - http://www.scopus.com/inward/record.url?scp=84937936952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937936952&partnerID=8YFLogxK
U2 - 10.3999/jscpt.46.115
DO - 10.3999/jscpt.46.115
M3 - Article
AN - SCOPUS:84937936952
SN - 0388-1601
VL - 46
SP - 115
EP - 125
JO - Japanese Journal of Clinical Pharmacology and Therapeutics
JF - Japanese Journal of Clinical Pharmacology and Therapeutics
IS - 3
ER -